Articles

A confirmed diagnosis of familial exudative vitreoretinopathy aids in several aspects of patient management

The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion

Phenocell and Amarna Therapeutics were awarded the grant by Eureka’s Eurostars initiative, co-funded by the European Union

A retrospective study assessed elevated neutrophil-to-lymphocyte ratios and systemic immune-inflammation index levels in patients with different subtypes of DMO

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children

Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications

Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy

The annual meeting brought fourth announcements and insights from companies in the retina care space

Lenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.

EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence

Breakthrough technologies are raising the ceiling for functional visual outcomes

What to expect from 4 days in the Fortezza de Basso

The differential recruitment of the dorsal and ventral visual streams

Gauging patient perceptions in an ethnically diverse UK cohort

The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries

The authors analysed severity and frequency of ocular pain among patients with DED living in altitudes above 2,500 meters during the COVID-19 pandemic

A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss

The annual meeting held in Chicago, Illinois, featured new data and best practices for patient-centred care

OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)

Uveitic relapses primarily manifest as anterior uveitis, the authors said

At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation

ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications

The incidence was comparable to that of daily wear soft contact lenses

OPUVIZ, previously known as the biosimilar candidate SB15, has been approved for the treatment of nAMD, DME and other retinal diseases

The positive opinion marks a key regulatory step towards the approval of FYB203, which will go by the trade names AHZANTIVE and Baiama in the European Union

The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration

Optical coherence tomography will be in all eye care services by October 2025

Assessing two devices in a real-world setting

The biosimilar to reference aflibercept (Eylea, Bayer AG) is indicated to treat retinal diseases including neovascular age-related macular degeneration

A coalition of eye health advocacy groups vocalised support for the legislation